These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18252933)

  • 21. Severe community-acquired pneumonia: an Australian perspective.
    Wilson PA; Ferguson J
    Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
    Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
    Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Infect Dis Clin North Am; 2009 Sep; 23(3):503-20. PubMed ID: 19665080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can we use severity assessment tools to increase outpatient management of community-acquired pneumonia?
    Chalmers JD; Rutherford J
    Eur J Intern Med; 2012 Jul; 23(5):398-406. PubMed ID: 22726367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Where to manage community acquired pneumonia? The assessment of severity].
    Bui HN; Vargas F; Gruson D; Hilbert G
    Rev Mal Respir; 2011 Feb; 28(2):240-53. PubMed ID: 21402237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community-acquired pneumonia in the intensive care unit.
    Leeper KV; Torres A
    Clin Chest Med; 1995 Mar; 16(1):155-71. PubMed ID: 7768089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia].
    Pişkin N; Aydemir H; Oztoprak N; Akduman D; Celebi G; Seremet Keskin A
    Mikrobiyol Bul; 2009 Oct; 43(4):597-606. PubMed ID: 20084912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Community-acquired pneumonia].
    Blanquer J; Sanz F
    Arch Bronconeumol; 2010 Oct; 46 Suppl 7():26-30. PubMed ID: 21316547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia.
    Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan J; Garnacho-Montero J; de la Torre MV; Sirvent JM; Bodi M
    Eur Respir J; 2006 Jun; 27(6):1210-6. PubMed ID: 16510452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Where should acquired community pneumonia be treated?].
    Zalacain R
    Med Clin (Barc); 2004 Apr; 122(13):496-8. PubMed ID: 15104945
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU.
    Restrepo MI; Mortensen EM; Velez JA; Frei C; Anzueto A
    Chest; 2008 Mar; 133(3):610-7. PubMed ID: 17989157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
    Rubulotta F; Ramsay D; Williams MD
    Crit Care Med; 2010 Apr; 38(4):1236; author reply 1236-7. PubMed ID: 20335730
    [No Abstract]   [Full Text] [Related]  

  • 33. Are the Australian guidelines asking too much of the Pneumonia Severity Index (PSI)?
    Buising KL; Thursky KA; Black JF; Brown GV
    Med J Aust; 2004 May; 180(9):486-7. PubMed ID: 15115434
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical policy for management and risk stratification of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria].
    Putinati S; Ballerin L; Piattella M; Ritrovato L; Zabini F; Potena A
    Recenti Prog Med; 2003 May; 94(5):199-203. PubMed ID: 12723497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What has Changed in Community-Acquired Pneumonia in Recent Years?
    Alfageme Michavila I
    Arch Bronconeumol; 2017 Jan; 53(1):3-4. PubMed ID: 27381971
    [No Abstract]   [Full Text] [Related]  

  • 36. Research in community-acquired pneumonia: the next steps.
    Torres A; Martín-Loeches I; Menéndez R
    Intensive Care Med; 2017 Sep; 43(9):1395-1397. PubMed ID: 28421245
    [No Abstract]   [Full Text] [Related]  

  • 37. CURB-65 and SMRT-CO in the prediction of early transfers to the intensive care unit among patients with community-acquired pneumonia initially admitted to a general ward.
    Huaman MA; Diaz-Kuan A; Hegab S; Brar I; Kaatz S
    J Hosp Med; 2011 Nov; 6(9):513-8. PubMed ID: 22042735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the real role of statins in community-acquired pneumonia and sepsis?
    Valente Barbas CS; Barbosa Kawano-Dourado L
    Crit Care Med; 2011 Aug; 39(8):1998-2000. PubMed ID: 21768804
    [No Abstract]   [Full Text] [Related]  

  • 39. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Hill AT
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Severity scores and factors related with mortality in cases with community-acquired pneumonia patients in intensive care unit].
    Doruk S; Bulaç S; Sevinç C; Bodur HA; Yilmaz A; Erkorkmaz U; Ocal S
    Tuberk Toraks; 2009; 57(4):393-400. PubMed ID: 20037854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.